-
Equivalence of family functioning and externalizing behaviors in adolescent substance users of different race/ethnicity.
Feaster DJ, Robbins MS, Henderson C, Horigian VE, Puccinelli MJ, Burlew AK, Szapocznik J. Equivalence of family functioning and externalizing behaviors in adolescent substance users of different race/ethnicity. Journal of Substance Abuse Treatment 2010;38(suppl 1):S113-S124.
-
From research to the real world: Buprenorphine in the decade of the Clinical Trials Network.
Ling W, Jacobs P, Hillhouse M, Hasson A, Thomas C, Freese TE, Sparenborg S, McCarty D, Weiss RD, Saxon AJ, Cohen AJ, Straus MM, Brigham GS, Liu DS, McLaughlin P, Tai B. From research to the real world: Buprenorphine in the decade of the Clinical Trials Network. Journal of Substance Abuse Treatment 2010;38(suppl 1):S53-S60.
-
Motivational incentives research in the National Drug Abuse Treatment Clinical Trials Network.
Stitzer ML, Petry NM, Peirce JM. Motivational incentives research in the National Drug Abuse Treatment Clinical Trials Network. Journal of Substance Abuse Treatment 2010;38(suppl 1):S61-S69.
-
Provision of ancillary medications during buprenorphine detoxification does not improve treatment outcomes.
Hillhouse M, Domier CP, Chim D, Ling W. Provision of ancillary medications during buprenorphine detoxification does not improve treatment outcomes. Journal of Addictive Diseases 2010;29(1):23-29.
-
OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: Racial/ethnic differences.
Covey LS, Hu M, Winhusen TJ, Weissman J, Berlin I, Nunes EV. OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: Racial/ethnic differences. Drug and Alcohol Dependence 2010;110(1-2):156-159.
-
Congratulations on the 10-year anniversary of the National Drug Abuse Treatment Clinical Trials Network — Now, what’s new for the coming decade? [editorial]
McLellan AT. Congratulations on the 10-year anniversary of the National Drug Abuse Treatment Clinical Trials Network -- Now, what's new for the coming decade? [editorial] Journal of Substance Abuse Treatment 2010;38(Suppl 1):S1-S3.
-
The first decade of the National Drug Abuse Treatment Clinical Trials Network: Bridging the gap between research and practice to improve drug abuse treatment.
Tai B, Straus MM, Liu DS, Sparenborg S, Jackson TR, McCarty D. The first decade of the National Drug Abuse Treatment Clinical Trials Network: Bridging the gap between research and practice to improve drug abuse treatment. Journal of Substance Abuse Treatment 2010;38(suppl 1):S4-S13.
-
Study results from the Clinical Trials Network’s first 10 years: Where do they lead?
Wells EA, Saxon AJ, Calsyn DA, Jackson TR, Donovan DM. Study results from the Clinical Trials Network's first 10 years: Where do they lead? Journal of Substance Abuse Treatment 2010;38(suppl 1):S14-S30.
-
Partnerships and pathways of dissemination: The National Institute on Drug Abuse – Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network.
Martino S, Brigham GS, Higgins C, Gallon S, Freese TE, Albright LM, Hulsey EG, Krom L, Storti SA, Perl HI, Nugent CD, Pintello D, Condom TP. Partnerships and pathways of dissemination: The National Institute on Drug Abuse - Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network. Journal of Substance Abuse Treatment 2010;38(suppl 1):S31-S43.
-
A longitudinal study of organizational formation, innovation of adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network.
Roman PM, Abraham AJ, Rothrauff TC, Knudsen HK. A longitudinal study of organizational formation, innovation of adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network. Journal of Substance Abuse Treatment 2010;38(suppl 1):S44-S52.